A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants

Status:
Recruiting

Trial end date:
2023-06-04

Target enrollment:

Participant gender:

The aim of the study is to describe the safety, tolerability, and immunogenicity of MenABCWY in healthy infants 2 and 6 months of age.

Phase 2

Pfizer

Acetaminophen